Search Results for agency_names:"Health and Human Services Department"

The Health Resources and Services Administration (HRSA) has issued a notice regarding petitions received under the National Vaccine Injury Compensation Program, part of the Public Health Service (PHS) Act. This program offers compensation to individuals who have been injured by specific childhood vaccines. Petitions are filed with the United States Court of Federal Claims, which appoints special masters to review cases. The notice details a list of petitions received in December 2020, and invites interested parties to submit relevant information concerning the petitions.

The Substance Abuse and Mental Health Services Administration (SAMHSA) is extending the approval of the current format for the annual Synar report, which monitors state compliance with laws prohibiting the sale of tobacco to those under 21. As part of the Block Grant funding requirements, states must enforce these laws, perform random inspections, and submit reports on their progress in reducing youth access to tobacco. Non-compliance may result in penalties or require states to undertake corrective action. Public comments on this information collection can be submitted within 30 days of this notice's publication.

The Centers for Medicare & Medicaid Services (CMS) is seeking public input on their plan to collect information from the public, as required by the Paperwork Reduction Act of 1995. This includes proposed new collections, extensions, or updates to existing collections. The public has until February 28, 2025, to submit comments. This process aims to ensure the information collected is necessary and useful, and help improve the quality and effectiveness of the information gathering methods used by the CMS.

The National Heart, Lung, and Blood Institute announced a closed meeting for its NHLBI Mentored Patient-Oriented Research Review Committee. The meeting is scheduled to take place virtually from March 4 to March 5, 2021, between 10:00 a.m. and 6:00 p.m. This session will focus on reviewing and evaluating grant applications. The meeting will be closed to the public to protect confidential information, including trade secrets and personal details related to the grant applications.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health, has announced a request for public comments on a proposed data collection project called the Data and Specimen Hub (DASH). This initiative aims to improve data sharing in biomedical research by allowing investigators to share and access de-identified study data and biospecimens. DASH will enable easier discovery and use of study data by cataloging information about studies and data collections stored in various public archives. The proposal seeks to continue collecting this information efficiently while minimizing the burden on those providing the data. Public comments are invited within 60 days from publication.

The Office of Child Care (OCC), a part of the Administration for Children and Families, is seeking public comments on a proposed application for disaster relief funds provided by the American Relief Act of 2025. These funds, totaling $250 million, are intended to help eligible states, territories, and tribes affected by major disasters in 2023 and 2024. The OCC is specifically interested in comments about the necessity and effectiveness of the information collection process, and they are considering setting predetermined funding grant ranges. Comments are due by March 18, 2025.

The Food and Drug Administration (FDA) has announced an opportunity for the public to comment on a proposed information collection related to establishment registration and product listing requirements for manufacturers of human blood, blood products, and licensed devices. This notice, part of the Paperwork Reduction Act of 1995, allows 60 days for public input. Comments can be submitted electronically via the Federal eRulemaking Portal or by mail, with detailed instructions provided by the FDA. The purpose of this information collection is to aid the FDA in inspecting facilities and ensuring the safety of the nation's blood supply.

The Food and Drug Administration (FDA) is withdrawing approval for two abbreviated new drug applications (ANDAs) from Flamingo Pharmaceuticals Ltd. This decision is because the company has consistently failed to submit the necessary annual reports for these drug applications. Despite being given a chance for a hearing, the company did not respond, resulting in a waiver of their hearing opportunity and any claims about the drug's legal status. Therefore, the approval for these drugs will officially be withdrawn on December 31, 2024.

The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, has announced a proposed information collection to study the long-term mental and physical health effects of COVID-19 on police officers. This study will build on previous research by the University of New York at Buffalo, which collected health data from police officers before the pandemic. The project aims to collect mental and physical health data from 200 officers over two rounds of data collection and invites public comments on its utility and burden. The study intends to understand how the pandemic has affected the well-being of police officers to improve their health and performance.

The Substance Abuse and Mental Health Services Administration's National Advisory Council (SAMHSA NAC) will hold a public virtual meeting on March 22, 2021, from 1:00 p.m. to 5:00 p.m. (ET). The meeting will cover updates on SAMHSA priorities, new grants, and initiatives, as well as a discussion on national issues in mental health and substance use. Interested persons can submit their views in writing or orally, with written submissions due seven days before the meeting. Details for attending the meeting and submitting comments are available on the SAMHSA website.